Oxford University Press, The Oncologist, 8(27), p. e681-e682, 2022
DOI: 10.1093/oncolo/oyac124
Export citation
Search in Google Scholar
Full text: Download
This letter to the editor considers outcomes for underrepresented populations across early phase pediatric oncology clinical trials, considering barriers to equitable representation of minorities in clinical trials.